Dr. Joseph JankowskiSr. Advisor to the Chief Innovation Officer Henry Ford Health System
In 2012, Dr. Joseph Jankowski joined Henry Ford Innovations as leader of its technology management group. An additional passion of Jankowski is teaching in the innovation and entrepreneurship space. He leads the HFHS Davidson Fellowship for Entrepreneurs in Digital Health, a monthly convening of System leaders who partner to assess and develop digital health innovations. Dr. Jankowski serves as Case Western Reserve University’s first Chief Innovation Officer. Alongside partners from the CWRU School of Law and Weatherhead School of Management, Jankowski co-founded and serves as an instructor in the CWRU “Fusion” program that educates integrated teams of JD, MBA and PhD students in the realms of intellectual property, commercialization and corporate finance and partnering. From 2003 to 2013, Jankowski directed the CWRU Technology Transfer Office (TTO). In this capacity, he led commercialization efforts for the University and its clinical affiliates that emanated from more than $300 million of research activity taking place at the CWRU and its affiliate institutions annually. Previously, Dr. Jankowski was a commercialization officer in the Office of Innovations at the Cleveland Clinic Foundation (CCF), a Technology Analyst in the Environmental Technology Commercialization Center at the Battelle Memorial Institute, and a research assistant with the SUNY Research Foundation. Dr. Jankowski holds a Ph.D. in Chemistry from the State University of New York’s College of Environmental Sciences, an M.B.A. from the Weatherhead School of Management and a dual B.S. in Chemical and Environmental Engineering Technologies from the University of Dayton.
What it Will take to Realize the Promise of Big Data, Connectivity and Machine Learning in Healthcare
There is immense potential for data-enabled technologies- MLA, IoT, AI and computational medicine – to transform healthcare. While early in their life cycle, we’ve already seen undeniable value propositions that range from patient-specific outcome improvements to efficiencies in system administration and population-level care. However, each any of these technologies are merely a tool and ultimate benefit will reside in the healthcare sector’s ability to appropriately utilize such tools. In this presentation, I will provide examples of high-value technology advances in care, coupled to discussion of current limitations that hinder wide-spread adoption and/or ultimate utility of such emerging interventions.